C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells

por Morimoto, Daishi, Matsumura, Shigeru, Bustos-Villalobos, Itzel, Sibal, Patricia Angela, Ichinose, Toru, Naoe, Yoshinori, Eissa, Ibrahim Ragab, Abdelmoneim, Mohamed, Mukoyama, Nobuaki, Miyajima, Noriyuki, Tanaka, Maki, Kodera, Yasuhiro, Kasuya, Hideki
Publicado 2021

The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers

por Eissa, Ibrahim Ragab, Bustos-Villalobos, Itzel, Ichinose, Toru, Matsumura, Shigeru, Naoe, Yoshinori, Miyajima, Noriyuki, Morimoto, Daishi, Mukoyama, Nobuaki, Zhiwen, Wu, Tanaka, Maki, Hasegawa, Hitoki, Sumigama, Seiji, Aleksic, Branko, Kodera, Yasuhiro, Kasuya, Hideki
Publicado 2018

Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth

por Wu, Zhiwen, Ichinose, Toru, Naoe, Yoshinori, Matsumura, Shigeru, Villalobos, Itzel Bustos, Eissa, Ibrahim Ragab, Yamada, Suguru, Miyajima, Noriyuki, Morimoto, Daishi, Mukoyama, Nobuaki, Nishikawa, Yoko, Koide, Yusuke, Kodera, Yasuhiro, Tanaka, Maki, Kasuya, Hideki
Publicado 2019

S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model

por Miyajima, Noriyuki, Ragab Eissa, Ibrahim, Abdelmoneim, Mohamed, Naoe, Yoshinori, Ichinose, Toru, Matsumura, Shigeru, Bustos-Villalobos, Itzel, Mukoyama, Nobuaki, Morimoto, Daishi, Shibata, Masahiro, Takeuchi, Dai, Tsunoda, Nobuyuki, Kikumori, Toyone, Tanaka, Maki, Kodera, Yasuhiro, Kasuya, Hideki
Publicado 2021